Scleroderma, Systemic: all 695 studies
Page 7 of 7. Open to participants first (224), then studies with results posted, then the rest; newest registration first within each.
- Proof of Biological Activity of SAR100842 in Systemic SclerosisCompletedNCT01651143Phase 2
- Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic SclerosisWithdrawnNCT01639573
- Serial Night Time Position Splint on Systemic SclerosisStatus unknownNCT01586663Phase 3
- Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung DiseaseCompletedNCT01570764Phase 3
- Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic StudyStatus unknownNCT01554540Phase 1/2
- A Trial of Tadalafil in Interstitial Lung Disease of SclerodermaCompletedNCT01553981Phase 3
- Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy PeoplesStatus unknownNCT01553890Not applicable
- Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse SclerodermaTerminatedNCT01545427Phase 2
- Probiotics in Patients With Moderate-to-severe Distention/ Bloating From Systemic SclerosisWithdrawnNCT01497743Phase 4
- Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic SclerosisCompletedNCT01488214Not applicable
- An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod)CompletedNCT01487551Phase 2
- Hemodynamic Changes in Connective Tissue DiseaseCompletedNCT01468792
- Immunoadsorption in Patients With Severe Systemic SclerosisTerminatedNCT01410903Not applicable
- Bosentan in Systemic SclerosisCompletedNCT01395732Phase 4
- Digital UlcerationCompletedNCT01377090
- Post Marketing Surveillance Study of CuprimineNo longer availableNCT01374282
- Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDYCompletedNCT01295736Phase 3
- Fresolimumab In Systemic SclerosisCompletedNCT01284322Phase 1
- Sonographic and Laboratory Evaluation of the Thyroid Gland in Patients With Systemic SclerosisCompletedNCT01270425
- Auto-immunity and Pulmonary Arterial HypertensionCompletedNCT01208792Not applicable
- Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis PatientsWithdrawnNCT01202045
- Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesStatus unknownNCT01151644Phase 4
- A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in SclerodermaCompletedNCT01117298Phase 3
- Finger Hardness Measure in SclerodermaCompletedNCT01111786
- Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic SclerosisWithdrawnNCT01047072Phase 2
- Influenza Vaccination in Patients With SclerodermaStatus unknownNCT01002508Phase 4
- Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary HypertensionCompletedNCT00984932Phase 3
- Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)Status unknownNCT00962923Phase 1/2
- Small Intestinal Mucosal Abnormalities in Systemic Sclerosis Using Capsule EndoscopyCompletedNCT00958672
- The Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00946738Not applicable
- A Study of the Safety and Tolerability of MEDI-551 in SclerodermaCompletedNCT00946699Phase 1
- A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With SclerodermaCompletedNCT00930683Phase 1
- Early Therapy of Pulmonary Arterial HypertensionCompletedNCT00909337Not applicable
- SCOT Scleroderma Treatment Alternative Registry (STAR Registry)CompletedNCT00860548
- Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate MofetilCompletedNCT00853788
- Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune DiseasesTerminatedNCT00849745Phase 1
- Pharmacokinetics of Oral Treprostinil in Patients With Systemic SclerosisCompletedNCT00848939Phase 1
- Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic SclerosisCompletedNCT00843102
- AIMSPRO in Established Diffuse Cutaneous Systemic SclerosisStatus unknownNCT00769028Phase 2
- Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual DysfunctionCompletedNCT00707187Phase 2
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)TerminatedNCT00706082
- Recombinant Human Relaxin in the Treatment of Diffuse SclerodermaCompletedNCT00704665Phase 3
- Cardiac Repercussion of Systemic SclerodermiasCompletedNCT00697736Not applicable
- Angiogenic/Angiostatic Mediators in Patients With Systemic SclerosisCompletedNCT00668473
- Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic SclerosisCompletedNCT00667134
- Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic SclerosisTerminatedNCT00628797Phase 1/2
- Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in SclerodermaCompletedNCT00626665Phase 3
- Sildenafil for Treatment of Digital Ulcers in Patients With Systemic SclerosisCompletedNCT00624273Phase 2
- Effect of Different Iloprost Doses on Symptoms in Systemic SclerosisTerminatedNCT00622687Phase 2
- Pulmonary Arterial Hypertension in Systemic SclerosisStatus unknownNCT00617487
- QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic SclerosisTerminatedNCT00581997Phase 2
- A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's PhenomenonStatus unknownNCT00577304Phase 3
- Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic SclerosisCompletedNCT00574613Phase 2
- Low-Dose Oral Imatinib for Scleroderma Pulmonary InvolvementStatus unknownNCT00573326Phase 2
- Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma PatientCompletedNCT00566137
- CLUE Study: Connective Tissue Disease Leg Ulcer Etiology StudyCompletedNCT00522002
- Duke Autoimmunity in Pregnancy RegistryCompletedNCT00513591
- Efficacy and Safety of Imatinib in SclerodermaCompletedNCT00479934Phase 2
- UVA1 Light for Treatment of Scleroderma and Similar ConditionsCompletedNCT00476801Not applicable
- UVA1 Light for Scleroderma and Similar ConditionsTerminatedNCT00476697Not applicable
- Platelet Gel in Systemic SclerosisStatus unknownNCT00463125Phase 2/3
- Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic SclerosisStatus unknownNCT00453752
- Mycophenolate Mofetil in Systemic SclerosisCompletedNCT00433186Phase 1
- High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic SclerosisStatus unknownNCT00428883Phase 2/3
- Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic SclerosisTerminatedNCT00418132Phase 1
- A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), RituximabCompletedNCT00379431Phase 2
- Dose Response Study of a Topical Gel for the Treatment of Raynaud's PhenomenonCompletedNCT00378521Phase 2
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma PatientsCompletedNCT00377949
- Premature Coronary Atherosclerosis in SclerodermaCompletedNCT00372398
- Efficacy and Safety Study of GB-0998 for Treatment of Systemic SclerosisCompletedNCT00348296Phase 3
- Open-label Study With Bosentan in Interstitial Lung DiseaseCompletedNCT00319033Phase 2/3
- Effects of a Personalized Standardized Rehabilitation Program in Systemic SclerosisCompletedNCT00318188Not applicable
- Effect of Bosentan on Skin Fibrosis in Patients With Systemic SclerosisCompletedNCT00318175Phase 2
- Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic SclerosisTerminatedNCT00282425Phase 1
- Rapamycin vs Methotrexate in Diffuse SScCompletedNCT00241189Phase 1/2
- Treatment of Early Systemic Sclerosis by BosentanTerminatedNCT00226889Phase 1/2
- Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 ControlsCompletedNCT00213525
- Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-upCompletedNCT00213460
- Imiquimod in Children With Plaque MorpheaCompletedNCT00147771Phase 3
- Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With SclerodermaCompletedNCT00077584Phase 3
- Scleroderma RegistryCompletedNCT00074568
- Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With SclerodermaCompletedNCT00070590Phase 2/3
- Stem Cell Transplant to Treat Patients With Systemic SclerosisCompletedNCT00058578Phase 1
- Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic SclerosisCompletedNCT00043706Phase 1/2
- Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma PatientsTerminatedNCT00040651Phase 1
- Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye SyndromeCompletedNCT00025818Phase 3
- Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic SclerosisCompletedNCT00016458Phase 2
- Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune DisordersCompletedNCT00010335Phase 1
- Psychological Treatments for SclerodermaCompletedNCT00007267Phase 2
- Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic SclerosisStatus unknownNCT00006393
- Oral Type I Collagen for Relieving SclerodermaCompletedNCT00005675Phase 2
- Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung DiseasesCompletedNCT00005317
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00004786Phase 3
- Phase II Study of Recombinant Relaxin for Progressive Systemic SclerosisCompletedNCT00004380Phase 2
- Study of Silicone-Associated Connective Tissue DiseasesCompletedNCT00001330